DiJoseph, J., Khandke, K., Dougher, M., Evans, D., Armellino, D., Hamann, P. and Damle, N. (2009) “CMC-544 (inotuzumab ozogamicin): A CD22-targeted immunoconjugate of calicheamicin”, Hematology Meeting Reports (formerly Haematologica Reports), 2(5). doi: 10.4081/hmr.v2i5.735.